Adverse reactions to BNT162B2 vaccine in health care workers from an Italian Tertiary Care Hospital

Clin Exp Allergy. 2022 Jul;52(7):911-915. doi: 10.1111/cea.14155. Epub 2022 May 10.

Authors

Valentina Guarnieri¹, Simona Barni², Mattia Giovannini^{1

2}, Giulia Liccioli², Lucrezia Sarti², Silvia Ricci^{1

3}, Lorenzo Lodi^{1

3}, Clementina Canessa^{1

3}, Francesca Lippi^{1

3}, Maria Moriondo^{1

3}, Laura Pisano^{1

3}, Francesco Citera^{1

3}, Chiara Azzari^{1

3}, Francesca Mori²

Affiliations

¹ Section of Pediatrics, Department of Health Sciences, University of Florence, Florence, Italy.
² Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
³ Immunology and Molecular Microbiology Unit, Meyer Children's Hospital, Florence, Italy.

No abstract available

Keywords: Pfizer-BioNTech's BNT162B2 vaccine; adverse reactions; allergy; hypersensitivity reactions; polyethylene glycol; skin prick test.

Publication types

Letter

MeSH terms

BNT162 Vaccine*
Health Personnel
Humans
Tertiary Care Centers
Vaccines*

Substances

Vaccines
BNT162 Vaccine